Do cancer survival statistics for every hospital make sense?

The Lancet Oncology

Volumn 17, Issue 9, 2016, Pages 1192-1194

  Morris, Melanie ^a   Quaresma, Manuela ^a   Pitkäniemi, Janne ^b   Morris, Eva ^c   Rachet, Bernard ^a   Coleman, Michel P ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b FINNISH CANCER REGISTRY   (Finland)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; DECISION MAKING; HEALTH CARE MANAGEMENT; HEALTH CARE SYSTEM; HEALTH SERVICE; HOSPITAL MORTALITY; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; NOTE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; TREND STUDY; UNITED KINGDOM; CANCER CENTER; DISEASE FREE SURVIVAL; HEALTH CARE QUALITY; HOSPITAL; MEASUREMENT ACCURACY; MORTALITY; NEOPLASM; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME;

DATA ACCURACY; DISEASE-FREE SURVIVAL; HOSPITAL MORTALITY; HOSPITALS; HUMANS; NEOPLASMS; ONCOLOGY SERVICE, HOSPITAL; PATIENT READMISSION; PROCESS ASSESSMENT (HEALTH CARE); QUALITY INDICATORS, HEALTH CARE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84994519219     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(16)30391-6     Document Type: Note

References (10)

1. 1 Dixon, A, Robertson, R, Appleby, J, Burge, P, Devlin, N, Magee, H, Patient choice: how patients choose and how providers respond, 2010, Kings Fund, London.
2. 2 Expert Advisory Group on Cancer. A policy framework for commissioning cancer services (Calman-Hine report), 1995, Department of Health, London.
3. 3 Independent Cancer Taskforce. Achieving world-class cancer outcomes: a strategy for England 2015–2020, 2015, NHS England, London.
4. 4 Rachet, B, Maringe, C, Nur, U, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 10 (2009), 351–369.
5. 5 Ellis, L, Rachet, B, Coleman, MP, Cancer survival indicators by Cancer Network: a methodological perspective. Health Stat Q 36 (2007), 36–41.
6. 6 Allemani, C, Weir, HK, Carreira, H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385 (2015), 977–1010.
7. 7 Quaresma, M, Coleman, MP, Rachet, B, Cancer survival indicators for Clinical Commissioning Groups in England: feasibility study, 2013, Department of Health, London.
8. 8 Walker, K, Neuburger, J, Groene, O, Cromwell, DA, Van der Meulen, J, Public reporting of surgeon outcomes: low numbers of procedures lead to false complacency. Lancet 382 (2013), 1674–1677.
9. 9 Spiegelhalter, DJ, Funnel plots for comparing institutional performance. Stat Med 24 (2005), 1185–1202.
10. 10 Seppä, K, Hakulinen, T, Läärä, E, Regional variation in relative survival—quantifying the effects of the competing risks of death by using a cure fraction model with random effects. J R Stat Soc Ser C (Appl Stat) 63 (2014), 175–190.